These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22929920)

  • 1. Hypofractionated conformal irradiation of patients with malignant glioma.
    Aboziada MA; Abo-Kresha AE
    J Egypt Natl Canc Inst; 2012 Sep; 24(3):139-43. PubMed ID: 22929920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial.
    Sultanem K; Patrocinio H; Lambert C; Corns R; Leblanc R; Parker W; Shenouda G; Souhami L
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):247-52. PubMed ID: 14697445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
    Reynaud T; Bertaut A; Farah W; Thibouw D; Crehange G; Truc G; Vulquin N
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818806498. PubMed ID: 30343637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in glioblastoma multiforme. 10 years experience of a single institution.
    Hulshof MC; Koot RW; Schimmel EC; Dekker F; Bosch DA; González González D
    Strahlenther Onkol; 2001 Jun; 177(6):283-90. PubMed ID: 11446316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.
    Prados MD; Wara WM; Sneed PK; McDermott M; Chang SM; Rabbitt J; Page M; Malec M; Davis RL; Gutin PH; Lamborn K; Wilson CB; Phillips TL; Larson DA
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):71-7. PubMed ID: 11163499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme.
    Floyd NS; Woo SY; Teh BS; Prado C; Mai WY; Trask T; Gildenberg PL; Holoye P; Augspurger ME; Carpenter LS; Lu HH; Chiu JK; Grant WH; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):721-6. PubMed ID: 14967426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated radiotherapy for elderly or younger low-performance status glioblastoma patients: outcome and prognostic factors.
    Chang EL; Yi W; Allen PK; Levin VA; Sawaya RE; Maor MH
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):519-28. PubMed ID: 12738329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifocal glioblastoma multiforme: prognostic factors and patterns of progression.
    Showalter TN; Andrel J; Andrews DW; Curran WJ; Daskalakis C; Werner-Wasik M
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):820-4. PubMed ID: 17499453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial).
    Mallick S; Kunhiparambath H; Gupta S; Benson R; Sharma S; Laviraj MA; Upadhyay AD; Julka PK; Sharma D; Rath GK
    J Neurooncol; 2018 Oct; 140(1):75-82. PubMed ID: 29936695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-course radiotherapy in elderly patients with glioblastoma: feasibility and efficacy of results from a single centre.
    Fariselli L; Pinzi V; Milanesi I; Silvani A; Marchetti M; Farinotti M; Salmaggi A
    Strahlenther Onkol; 2013 Jun; 189(6):456-61. PubMed ID: 23625362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Choice of fractionation regimen for Grade IV gliomas depending on rapid early progression].
    Chuguev AS; Kobyletskaya TM; Gerasimov VA; Belikova AA; Kaprin AD; Datsenko PV
    Zh Vopr Neirokhir Im N N Burdenko; 2024; 88(5):23-29. PubMed ID: 39422680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma.
    Combs SE; Edler L; Rausch R; Welzel T; Wick W; Debus J
    Acta Oncol; 2013 Jan; 52(1):147-52. PubMed ID: 22686472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute toxicity and changes in quality of life during a combined radio-chemotherapy of glioblastomas with topotecan (Hycamtin).
    Gross MW; Altscher R; Brandtner M; Häusser-Mischlich H; Kiricuta IC; Siegmann AD; Engenhart-Cabillic R
    Strahlenther Onkol; 2001 Dec; 177(12):656-61. PubMed ID: 11789404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
    Prados MD; Scott CB; Rotman M; Rubin P; Murray K; Sause W; Asbell S; Comis R; Curran W; Nelson J; Davis RL; Levin VA; Lamborn K; Phillips TL
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):653-9. PubMed ID: 9486616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of hypofractionated radiation therapy in elderly patients with newly diagnosed glioblastoma with poor prognosis.
    Navarria P; Pessina F; Cozzi L; Tomatis S; Reggiori G; Simonelli M; Santoro A; Clerici E; Franzese C; Carta G; Conti Nibali M; Bello L; Scorsetti M
    Tumori; 2019 Feb; 105(1):47-54. PubMed ID: 30131010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study.
    Jeremic B; Grujicic D; Antunovic V; Djuric L; Stojanovic M; Shibamoto Y
    Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1179-85. PubMed ID: 7961028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypofractionated irradiation for gliomas with 45.5Gy in 13 fractions: a retrospective study.
    Kouloulias V; Zygogianni A; Kouvaris J; Platoni K; Georgakopoulos J; Boviatsis E; Beli I; Tolia M; Antypas C; Karaiskos P; Scarleas C; Asimakopoulos C; Pantelakos P; Kelekis N
    J Neurosurg Sci; 2015 Dec; 59(4):447-53. PubMed ID: 26635192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The results of hypofractionated radiotherapy in 31 patients with high-grade gliomas.
    Sayin MY; Kaya B; Bakkal BH; Altundag K; Altundag MB
    Med Oncol; 2007; 24(4):379-83. PubMed ID: 17917085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent accelerated hyperfractionated radiation therapy and carboplatin/etoposide in patients with malignant glioma: long-term results of a phase II study.
    Jeremic B; Shibamoto Y; Grujicic D; Stojanovic M; Milicic B; Nikolic N; Dagovic A; Aleksandrovic J
    J Neurooncol; 2001 Jan; 51(2):133-41. PubMed ID: 11386410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.
    Lipani JD; Jackson PS; Soltys SG; Sato K; Adler JR
    Technol Cancer Res Treat; 2008 Jun; 7(3):249-55. PubMed ID: 18473497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.